Many of the diagnoses that unlock GLP-1 Bridge eligibility are biomarker-driven
Rapid GLP-1 weight loss often leaves loose skin and softened contours across the face (often referred to as Ozempic face), neck, jawline, and body
Since the mid-1950s, scientists have also been aware of the ability of B12 to process and burn fat
During the Super Bowl, telehealth platform Hims & Hers released a controversial ad calling out drugmakers that provide weight loss drugs priced for profits, not patients. It then proceeded to highlight its compounded GLP-1 offerings, calling them affordable, doctor-trusted and formulated in the USA. Shortly after, Novo Nordisk responded to the ad with its own Check before you inject campaign, highlighting the argument that patients should be wary of compounded GLP-1s given that they arent FDA-approved products
Medical knowledge evolves continuously, and information that is current at time of publication may become outdated as new research emerges